Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without...
Principais autores: | Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Wiley
2022-07-01
|
coleção: | Cancer Medicine |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1002/cam4.4644 |
Registros relacionados
-
Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer
por: Mohammad Shahbazi, et al.
Publicado em: (2023-02-01) -
Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
por: Puja Aggarwal, et al.
Publicado em: (2023-01-01) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
por: Ryan J. Longenecker, et al.
Publicado em: (2021-09-01) -
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
por: Mohammad Shahbazi, et al.
Publicado em: (2024-11-01) -
Topical gentamicin-induced acute vestibulopathy: A case report
por: Teik Beng Lau, et al.
Publicado em: (2023-05-01)